Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,979
Closed -$599K 194
2022
Q3
$599K Buy
15,979
+23
+0.1% +$912 0.16% 73
2022
Q2
$586K Buy
15,956
+875
+6% +$36.2K 0.15% 76
2022
Q1
$739K Buy
15,081
+272
+2% +$13.8K 0.16% 67
2021
Q4
$709K Buy
+14,809
New +$701K 0.15% 76

Other funds holding SNV

CFO4Life Group's SNV Position: Q4 2022 in Review

CFO4Life Group sold out of Synovus (SNV) in Q4 2022, closing a stake of 15,979 shares — an estimated $599K sold.

CFO4Life Group first reported a position in SNV in Q4 2021 and held it in 4 quarters. The position peaked at $739K in Q1 2022. 419 funds tracked by Wall St. Rank hold SNV as of Q4 2022.

  • CFO4Life Group reported no remaining Synovus position as of Q4 2022 after selling out during the quarter.
  • CFO4Life Group sold 15,979 Synovus shares in Q4 2022, an estimated $599K.
  • CFO4Life Group first reported a position in Synovus in Q4 2021 and held it in 4 quarters.
  • CFO4Life Group's Synovus position peaked at $739K in Q1 2022.
  • 419 funds tracked by Wall St. Rank held Synovus as of Q4 2022.

Based on CFO4Life Group's 13F filing for Q4 2022, filed 3 Feb 2023.